Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Toxicol Lett ; 294: 135-144, 2018 Sep 15.
Article in English | MEDLINE | ID: mdl-29778911

ABSTRACT

Di(2-ethylhexyl) phthalate (DEHP) is a widely used plasticizer that is metabolized to mono(2-ethylhexyl) phthalate (MEHP). Inhalation is an important exposure route for both phthalates, and their effects on lungs include inflammation, alteration of postnatal maturation (alveolarization), enlarged airspaces and cell differentiation changes, suggesting that alveolar epithelial cells-2 (AEC) are targets of phthalates. This study evaluated the cell progression, epithelial and mesenchymal markers, including surfactant secretion in A549 cells (AEC) that were exposed to DEHP (1-100 µM) or MEHP (1-50 µM) for 24-72 h. The results showed an increased cell proliferation at all concentrations of each phthalate at 24 and 48 h. Cell migration showed a concentration-dependent increase at 24 and 48 h of exposure to either phthalate and enlarged structures were seen. Decreased levels of both surfactants (SP-B/SP-C) were observed after the exposure to either phthalate at 48 h, and of SP-C positive cells exposed to MEHP, suggesting a loss of the epithelial phenotype. While a decrease in the epithelial marker E-cadherin and an increase in the mesenchymal marker fibronectin were observed following exposure to either phthalate. Our results showed that DEHP and MEHP altered the structure and migration of A549 cells and promoted the loss of the epithelial phenotype.


Subject(s)
Alveolar Epithelial Cells/drug effects , Cell Dedifferentiation/drug effects , Diethylhexyl Phthalate/analogs & derivatives , Diethylhexyl Phthalate/toxicity , Plasticizers/toxicity , Pulmonary Surfactant-Associated Protein B/antagonists & inhibitors , Pulmonary Surfactant-Associated Protein C/antagonists & inhibitors , A549 Cells , Alveolar Epithelial Cells/cytology , Alveolar Epithelial Cells/metabolism , Antigens, CD , Biomarkers/metabolism , Cadherins/antagonists & inhibitors , Cadherins/metabolism , Cell Movement/drug effects , Cell Proliferation/drug effects , Cell Shape/drug effects , Cell Size/drug effects , Cell Survival/drug effects , Fibronectins/agonists , Fibronectins/metabolism , Humans , Kinetics , Pulmonary Surfactant-Associated Protein B/metabolism , Pulmonary Surfactant-Associated Protein C/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL